MedTrace Logo

Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke

NCT05169450 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 998

Last updated 2021-12-27

No results posted yet for this study

Summary

A randomized positived-controlled study of Diterpene Ginkgolides Meglumine Injection (DGMI) vs Ginaton in patients with ischemic stroke (IS) was conducted between7/2013 and 4/2014. The study was designed to test efficacy of DGMI for IS. Post hoc analysis of this trial was conducted to evaluate the efficacy of DGMI in elderly (aged≥65 years) IS patients.

Conditions

Interventions

DRUG

Diterpene ginkgolides meglumine injection

Patients will receive intravenously administered diterpene ginkgolides meglumine injection, combined with guidelines-based standard care.

DRUG

Ginaton

Patients will receive intravenously administered Ginaton, combined with guidelines-based standard care.

Sponsors & Collaborators

  • Dongzhimen Hospital, Beijing

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-01
Primary Completion
2014-04-01
Completion
2014-04-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05169450 on ClinicalTrials.gov